Stay updated on LITT with Checkpoint Inhibitor for RGBM Clinical Trial
Sign up to get notified when there's something new on the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page.

Latest updates to the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page
- Check5 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 is shown on the page, replacing the previous Revision: v3.4.1.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision header updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedGlossary toggle added (Show glossary); Study Record Dates now show 'Last Update Submitted that Met QC Criteria' and a new 'Revision: v3.4.0' label, while the older 'Last Update Submitted that met QC Criteria' label and 'No FEAR Act data' were updated to 'No FEAR Act Data' and the previous 'Revision: v3.3.4' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedStudy status updated to Active, not recruiting with new 2026 dates and revision to v3.3.4. The prior Recruiting status and the study contact details have been removed.SummaryDifference1%

- Check84 days agoChange DetectedNew: Locations section now includes Ohio as a recruitment site. Removed: Ohio Locations and HHS Vulnerability Disclosure link; page updated to Revision: v3.3.3.SummaryDifference0.2%

Stay in the know with updates to LITT with Checkpoint Inhibitor for RGBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page.